Cardlytics Inc risk profile
59 Elevated one input has moved against it
Measured 21 October 2026 from CDLX's filed statements. Recomputed nightly.
59 (Elevated), driven by Concentration at 85, over 5 weighted categories on the SOFTWARE profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | Reads pct_below_52w_high, volatility_1y_pct and avg_turnover_90d_usd. No reading is stored for this company. | |||
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 32 | Normal | Easing | Free-cash-flow margin — 4.1% |
| Leverage and coverage | 53 | Elevated | Easing | Net debt to EBITDA |
| Competitive position | 77 | Stretched | Stable | Operating-margin gap against peers — -42.4 percentage points |
| Concentration | 85 | Acute | Stable | Geographic concentration — 7,740 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.